openPR Logo
Press release

Radiation Nephropathy Treatment and Management Market Emerging Economies Expected to Influence Growth until 2028

11-16-2018 08:44 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Radiation Nephropathy Treatment and Management Market

Radiation nephropathy is renal injury and loss of function affected by ionizing radiation. The major risk with radiation nephropathy and bone marrow transplant (BMT) nephropathy is progressive loss of renal function with evolution to end-stage renal failure. The radiation nephropathy usually occurs after sufficient irradiation of both kidneys. The renal failure may be accelerated due to uncontrolled hypertension, hence to control the loss of renal function, blood pressure must be maintained. Thus, antihypertensive agents are an important part of clinical management of radiation nephropathy or BMT nephropathy. The goal of therapy is to keep blood pressure at less than 130/85 mm Hg or 125/75 mm Hg if the patient has proteinuria of greater than 1000 mg/d.

Moreover, due to its uncommon characteristics, there are no controlled trials to guide the management of radiation nephropathy. Hence, radiation nephropathy treatment and management is guided by the same principles of treatment of any hypertensive kidney disease, including renovascular hypertension, blood pressure control and correction of metabolic acidosis. The most important blood pressure medications to treat renal hypertension include: ACE inhibitors (angiotensin converting enzyme inhibitors). These include ramipril, benazepril, captopril, lisinopril, and others; and ARBs (angiotensin II receptor blockers). Examples include candesartan, losartan, olmesartan and valsartan. However, some people with renal hypertension can be helped by angioplasty, stenting, or surgery on the blood vessels of the kidney.

Radiation Nephropathy Treatment and Management Market: Drivers and Restraints

Radiation nephropathy treatment and management market is majorly driven by increasing prevalence of kidney disorders and rising patient population suffering from hypertension. Renovascular hypertension is said to be the main cause of chronic kidney disorder. In 2013, in U.S. approximately, 661,000 American have kidney failure and in 2013 more than 47,000 Americans died from kidney disease. Moreover, government initiatives to increase early awareness about radiation nephropathy treatment and management, are also driving the radiation nephropathy treatment and management market. For instance, private and public healthcare organization is increasingly taking initiatives for management of kidney diseases which is expected to spur the growth of radiation nephropathy treatment and management market. In addition to this, National Institute of Diabetes and Kidney Diseases (NIDDK), National Institutes of Health (NIH) and CDC conduct screening programs and support research into many diseases and conditions. Also, increasing number of patients suffering from cholesterol and diabetes are also likely to create high demand of radiation nephropathy treatment and management. Moreover, aggregate prevalence of primary renal diseases such as renal artery stenosis, atherosclerosis, and focal segmental glomerulosclerosis is also one of the key factors driving the radiation nephropathy treatment and management market.

Besides this, upsurge in clinical trial for drug development with the support of government organization is also likely to spur the growth of radiation nephropathy treatment and management market. However, less awareness regarding renovascular hypertension due to no symptoms is the major factor expected to restrain radiation nephropathy treatment and management market.

Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1688 

 Radiation Nephropathy Treatment and Management Market: Segmentation

Tentatively, the global radiation nephropathy treatment and management market can be segmented on the basis of drug type, mode of administration, distribution channel, and geography.

Based on drug type, the global radiation nephropathy treatment and management market is segmented as:

Angiotensin Converting Enzyme (ACE) Inhibitor
Diuretic
Angiotensin II Receptor Blockers (ARBs)
Vasodilators
Calcium Channel Blockers
Others
Based on mode of administration, the global radiation nephropathy treatment and management market is segmented as:

Oral
Injectable
Based on distribution channel, the global radiation nephropathy treatment and management market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Radiation Nephropathy Treatment and Management Market: Overview

The global market for radiation nephropathy treatment and management is expected to witness moderate growth during the forecast period. Angiotensin-converting enzyme (ACE) inhibitor is expected to contribute major revenue share in radiation nephropathy treatment and management market. In addition with ACE inhibitor or angiotensin II receptor blockers, diuretic drugs are also prescribed to control the renal hyper. Hypertensive, which is driving the radiation nephropathy treatment and management market.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1688 

Radiation Nephropathy Treatment and Management Market: Regional Outlook

Geographically, the global radiation nephropathy treatment and management market is segmented into viz. North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America and Europe is expected to be the dominant market in the global radiation nephropathy treatment and management market owing to large patient pool. The radiation nephropathy treatment and management market in the Asia Pacific excluding Japan is expected to grow at a high CAGR due to the increasing healthcare expenditure and growing healthcare facilities.

Radiation Nephropathy Treatment and Management Market: Key Players

Examples of some of the key players operating in the global radiation nephropathy treatment and management market are Silvergate Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc., Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Novartis Pharmaceuticals Corporation, Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, ALEMBIC PHARMS LTD, Daiichi Sankyo GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. and others. Companies are conducting clinical trials for the development of new radiation nephropathy treatment and management drugs which expected to provide the high growth opportunity for radiation nephropathy treatment and management market.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
CIS & Russia
Japan
Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/1688/radiation-nephropathy-treatment-and-management-market 

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiation Nephropathy Treatment and Management Market Emerging Economies Expected to Influence Growth until 2028 here

News-ID: 1375943 • Views: 207

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Fact.MR
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases


More Releases for Radiation

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market …
QY Market Insights added Latest Research Report titled Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2018 by Manufacturers, Regions, Product Type and Application, Forecast to 2025 to its Large Report database. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market. Get Free Sample Report at: https://www.qymarketinsights.com/report-detail/54739/request-sample The Report highlights key
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market …
Qyresearchreports include new market research report "Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Status and Forecast 2025" to its huge collection of research reports. A newly added research report about the global market for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) produces a 360-degree overview of it. The report brings to the fore important details and elucidates every aspect expected to mold its path going forward. It sheds
Global Radiation Toxicity Market: Radiation Sickness, Acute Radiation Syndrome - …
"The Latest Research Report Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Radiation ToxicityRadiation Toxicity Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Pipeline Review, H2 2017, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline landscape. Radiation Toxicity
Radiation Hardened Electronics Market Technological Advancements 2024
An act of producing the electronic systems or components resistant to malfunction or damage done by ionizing radiation (electromagnetic radiation and particle radiation of high energy) is called as radiation hardening. These radiations are encountered in high-altitude flight and outer space, around particle accelerators and nuclear reactors, or during nuclear wars and nuclear accidents. Most of the electronic components are prone to damage by these radiations. However radiation hardened electronic
Global Radiation Door Market 2016
This report studies Global Radiation Door Market 2016, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Bluestar Chemical mMachinery Jiangsu Baishi Cheng Hazlin Lindner Group Van Vuuren Download Sample this Report: http://globalqyresearch.com/download-sample/140391 Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Radiation
Global Oncology Radiation Therapy Market Technology 2023
Radiation therapy refers to the medical use of targeted energy such as radioactive substances, x-rays etc., to destroy or kill cancerous cells without affecting the nearby healthy tissues. This therapy can be deployed as a sole therapy or as an adjuvant therapy, or it can also be employed to shrink the tumor cells, reduce pain and pressure or any other symptoms of cancer (also known as palliative radiation therapy). Currently,